Cretostimogene demonstrated HG-EFS at 3- 6- and 9-months of 95.7%, 84.6% and 80.4%, respectively, in HR BCG UR Ta/T1 Disease…
AI-Driven Risk Prediction for Breast, Prostate and Pancreatic CancersTOKYO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (Japanese Name:…
Interim data show substantial improvements in “Good On” time compared to other oral CD/LD therapiesCREXONT delivered substantial “Off” time reductions,…
RADNOR, Pa., Dec. 4, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services…
Extends cash runway into first half of 2028, beyond planned completion of ViraxImmune™ US based regulatory study in post-acute sequelae of…
ADDISON, Texas, Dec. 4, 2025 /PRNewswire/ -- HaloMD today announced the addition of three established executive experts across data, technology, and…
AUSTIN, Texas, Dec. 4, 2025 /PRNewswire/ -- PerfectQuote, Inc., the leading group health digital quoting and distribution platform, has announced…
Major Regulatory Milestone: The first Canadian-developed AI for ICH triage receives FDA clearance to enter the U.S. market.Operational Value: Automates…
Partnership Creates Synergy Between Both Companies in Advanced Technologies and Support Services for Drug DiscoveryMELVILLE, N.Y., Dec. 4, 2025 /PRNewswire/…
Powering the Cost Plus Marketplace for Businesses Through Transparency, Innovation and Trust NASHVILLE, TENNESSEE / ACCESS Newswire / December 4,…